Donor Recruitment for Fecal Microbiota Transplantation

被引:117
作者
Paramsothy, Sudarshan [1 ,2 ,3 ,4 ]
Borody, Thomas J. [5 ]
Lin, Enmoore [5 ]
Finlayson, Sarah [5 ]
Walsh, Alissa J. [1 ]
Samuel, Douglas [2 ]
van den Bogaerde, Johan [3 ]
Leong, Rupert W. L. [2 ]
Connor, Susan [6 ]
Ng, Watson [6 ]
Mitchell, Hazel M. [4 ]
Kaakoush, Nadeem [4 ]
Kamm, Michael A. [7 ,8 ,9 ]
机构
[1] St Vincents Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW 2010, Australia
[2] Bankstown Lidcombe Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW, Australia
[3] Nambour Gen Hosp, Dept Gastroenterol & Hepatol, Nambour, Australia
[4] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia
[5] Ctr Digest Dis, Sydney, NSW, Australia
[6] Liverpool Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW, Australia
[7] St Vincents Hosp, Dept Gastroenterol & Hepatol, Melbourne, Vic 3065, Australia
[8] Univ Melbourne, Melbourne, Vic, Australia
[9] Univ London Imperial Coll Sci Technol & Med, London, England
关键词
fecal microbiota transplantation; fecal donor; donor screening; CLOSTRIDIUM-DIFFICILE INFECTION; HUMAN GUT MICROBIOME; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INTESTINAL MICROBIOTA; CROHNS COLITIS; DIARRHEA; BACTERIOTHERAPY; PREVENTION; REMISSION;
D O I
10.1097/MIB.0000000000000405
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Increasing demand for fecal microbiota transplantation (FMT) has created a need for stool banks sourced from long-term healthy donors. Here, we describe our experience in recruiting and screening fecal donors.Methods:Mailbox, newspaper, and online advertisements were used. Potential donors were required to satisfy a prescreen telephone conversation, pass blood and stool investigations, then undertake a screening interview including medical history, physical examination, and evaluation of donor selection criteria.Results:One hundred sixteen potential donors were prescreened of whom 74 failed47 declined based on study donation requirements (primarily related to frequency and duration of donations), 13 had medical comorbidities, 6 variant Creutzfeldt-Jakob disease risk factors, 8 for other reasons. Thirty-eight completed stool and blood testing1 failed blood testing (indeterminate hepatitis C serology), whereas 15 failed stool investigations (5 Dientamoeba fragilis, 5 Blastocystis hominis, 1 B. hominis and D. fragilis, 1 Giardia intestinalis plus D. fragilis, 1 Norovirus plus Clostridium difficile toxin positive, and 2 leucocytes or erythrocytes on stool microscopy). Of the 18 potential donors proceeding to screening interview, 6 were excluded (3 body mass index >30, 1 illicit drug use, 1 uncontrolled anxiety and concerns regarding compliance, 1 irregular bowel movements after new medication commencement). In total, only 12 of 116 (10%) potential donors were enrolled as study donors.Conclusions:Recruitment of fecal donors for FMT is challenging with only a small percentage ultimately serving as donors. Many were unable or unwilling to meet the donor commitment requirements. A surprisingly large proportion of healthy asymptomatic donors failed stool testing, primarily due to gastrointestinal parasites.
引用
收藏
页码:1600 / 1606
页数:7
相关论文
共 41 条
[1]   Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease [J].
Anderson, J. L. ;
Edney, R. J. ;
Whelan, K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (06) :503-516
[2]   Temporal Bacterial Community Dynamics Vary Among Ulcerative Colitis Patients After Fecal Microbiota Transplantation [J].
Angelberger, Sieglinde ;
Reinisch, Walter ;
Makristathis, Athanasios ;
Lichtenberger, Cornelia ;
Dejaco, Clemens ;
Papay, Pavol ;
Novacek, Gottfried ;
Trauner, Michael ;
Loy, Alexander ;
Erry, David B. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (10) :1620-1630
[3]  
[Anonymous], JOINT SOC LETT FDA C
[4]   Treating Clostridium difficile Infection With Fecal Microbiota Transplantation [J].
Bakken, Johan S. ;
Borody, Thomas ;
Brandt, Lawrence J. ;
Brill, Joel V. ;
Demarco, Daniel C. ;
Franzos, Marc Alaric ;
Kelly, Colleen ;
Khoruts, Alexander ;
Louie, Thomas ;
Martinelli, Lawrence P. ;
Moore, Thomas A. ;
Russell, George ;
Surawicz, Christina .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (12) :1044-1049
[5]   A review of Dientamoeba fragilis carriage in humans Several reasons why this organism should be considered in the diagnosis of gastrointestinal illness [J].
Barratt, Joel L. N. ;
Harkness, John ;
Marriott, Deborah ;
Ellis, John T. ;
Stark, Damien .
GUT MICROBES, 2011, 2 (01) :3-12
[6]   Clostridium difficile Infection in the Inflammatory Bowel Disease Patient [J].
Berg, Adam M. ;
Kelly, Ciaran P. ;
Farraye, Francis A. .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (01) :194-204
[7]   Therapeutic faecal microbiota transplantation: current status and future developments [J].
Borody, Thomas J. ;
Brandt, Lawrence J. ;
Paramsothy, Sudarshan .
CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (01) :97-105
[8]   Treatment of ulcerative colitis using fecal bacteriotherapy [J].
Borody, TJ ;
Warren, EF ;
Leis, S ;
Surace, R ;
Ashman, O .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (01) :42-47
[9]   An overview of fecal microbiota transplantation: techniques, indications, and outcomes [J].
Brandt, Lawrence J. ;
Aroniadis, Olga C. .
GASTROINTESTINAL ENDOSCOPY, 2013, 78 (02) :240-249
[10]   Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection [J].
Brandt, Lawrence J. ;
Aroniadis, Olga C. ;
Mellow, Mark ;
Kanatzar, Amy ;
Kelly, Colleen ;
Park, Tina ;
Stollman, Neil ;
Rohlke, Faith ;
Surawicz, Christina .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07) :1079-1087